OpenAlex
PricingAboutJobs
Log inGet started
Work

Metabolic and ovarian effects of rosiglitazone treatment for 12 weeks in insulin-resistant women with polycystic ovary syndrome

HTML

Year: 2005
Type: article
Study design: Clinical Trial
Source: Human Reproduction
DOI: 10.1093/humrep/dei289
Authors: Nicholas A. Cataldo, Fahim Abbasi, Tracey L. McLaughlin, Marina Basina, Patricia Y. Fechner, Linda C. Giudice, Gerald M. Reaven
Institutions: Stanford Medicine, Stanford University
Language: English

Topic: Ovarian function and disorders
Subfield: Reproductive Medicine
Field: Medicine
Domain: Health Sciences
Keywords: rosiglitazone, polycystic ovary syndrome, insulin resistance, thiazolidinediones, ovulation, menstrual pattern, insulin sensitivity, insulin levels, testosterone, sex hormone-binding globulin, luteinizing hormone, dose dependence, insulin-sensitizing drugs
SDG: Good health and well-being

Open Access status: closed

Funders: National Institutes of Health, National Center for Research Resources, Eunice Kennedy Shriver National Institute of Child Health and Human Development
Awards: ROSIGLITAZONE IN POLYCYSTIC OVARY SYNDROME, General Clinical Research Center
OpenAlex ID: W2105243339
FWCI: 8.416
Cites: 62
Cited by: 76
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms
Security